Delineation of target volumes and organs at risk in conformal radiotherapy for the prostate cancer: French trials of dose escalation;Délimitation des volumes-cibles et des organes critiques pour la radiothérapie conformationnelle du cancer de la prostate: Expérience des essais français d'escalade de dose

Cancer/Radiotherapie

Volumn 6, Issue SUPPL. 1, 2002, Pages

  Beckendorf, V ^a   Bachaud, J M ^b   Bey, P ^a   Bourdin, S ^c   Carrie, C ^d   Chapet, O ^e   Cowen, D ^f   Guerif S ^g   Hay, H M ^h   Lagrange, J L ⁱ   Maingon, P ^j   Le Prise E ^k   Pommier, P ^d   Simon, J M ^l  

^a CENTRE ALEXIS VAUTRIN   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c CENTRE RENÉ GAUDUCHEAU   (France)

^d CENTRE LÉON BÉRARD   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f TIMONE HOSPITAL   (France)

^g University of Poitiers   (France)

^h CENTRE VAL D AURELLE   (France)

ⁱ CENTRE ANTOINE LACASSAGNE   (France)

^j CENTRE GEORGES FRANÇOIS LECLERC   (France)

^k CENTRE EUGÈNE MARQUIS   (France)

^l PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

Conformal radiotherapy; Prostatic neoplasms; Radiotherapy planning

Indexed keywords

ANATOMY; BLADDER WALL; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DOSIMETRY; HUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RECTUM; SEMINAL VESICLE; TUMOR VOLUME; URETHRA;

ADENOCARCINOMA; ANAL CANAL; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FRANCE; GENITALIA, MALE; HUMANS; MALE; ORGAN SPECIFICITY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; TREATMENT OUTCOME; URINARY BLADDER;

EID: 0036869017     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. Algan O, Hanks GE, Shaer AH. Localization of the prostatic apex for radiation treatment planning. Int J Radiat Oncol Biol Phys 1995;33:925-30.
2. Austin-Seymour M, Chen GT, Rosenman J, Michalski J, Lindsley K, Goitein M. Tumor and target delineation: Current research and future challenges. Int J Radiat Oncol Biol Phys 1995;33:1041-52.
3. Beckendorf V, Elles S, Madelis G, Aletti P, Baumann P, Bollet M, et al. Postoperative radiation therapy in lung cancer: Clinical target volume delineation in a workshop including radiation oncologists and radiologists. 19th Annual European Society for Therapeutic Radiology and Oncology Meeting 2000 (Abstract 621) 2000;56(suppl 4):S163.
4. Berthelet E, Liu MC, Agranovich A, Patterson K, Currie T. Computed tomography determination of prostate volume and maximum dimensions: A study of interobserver variability. Radiother Oncol 2002;63:37-40.
5. Bey P, Carrie C, Beckendorf V, Ginestet C, Aletti P, Madelis G, et al. Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results. Int J Radiat Oncol Biol Phys 2000;48:513-7.
6. Bieri S, Miralbell R, Nouet P, Delorme H, Rouzaud M. Reproducibility of conformal radiation therapy in localized carcinoma of the prostate without rigid immobilization. Radiother Oncol 1996;38:223-30.
7. Boersma LJ, van den Brink M, Bruce AM, Shouman T, Gras L, te Velde A, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998;41:83-92.
8. Boisserie G, Hasboun D. Usage de l'imagerie en multimodalité en radiothérapie. Cancer Radiother 2001;5:15S-35S.
9. Cazzaniga LF, Marinoni MA, Bossi A, Bianchi E, Cagna E, Cosentino D, et al. Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother Oncol 1998;47:293-6.
10. Dawson LA, Litzenberg DW, Brock KK, Sanda M, Sullivan M, Sandler HM, et al. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys 2000;48:319-23.
11. Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet 1999;353:267-72.
12. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
13. Fiorino C, Reni M, Bolognesi A, Bonini A, Cattaneo GM, Calandrino R. Set-up error in supine-positioned patients immobilized with two different modalities during conformal radiotherapy of prostate cancer. Radiother Oncol 1998;49:133-41.
14. Fiorino C, Reni M, Bolognesi A, Cattaneo GM, Calandrino R. Intra-and inter-observer variability in contouring prostate and seminal vesicles: Implications for conformal treatment planning. Radiother Oncol 1998;47:285-92.
15. Garcia R, Oozeer R, Le Thanh H, Chauvet B, Toy BJ, Reboul F. Radiothérapie conformationnelle des cancers de prostate: Apport de la contention pelvienne et de nouveaux repères de positionnement. Cancer Radiother 1997;1:307-13.
16. Giraud P, Elles S, Helfre S, De Rycke Y, Servois V, Carette MF, et al. Conformal radiotherapy for lung cancer: Different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 2002;62:27-36.
17. Hanks GE, Hanlon AL, Schultheiss TE, Pinover WH, Movsas B, Epstein BE, et al. Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998;41:501-10.
18. ICRU. ICRU Report 50. Prescribing, Recording and Reporting Photon Beam Therapy. Series Editor. Bethesda, MD: International Commission of Radiation Units and Measurements; 1993.
19. ICRU. ICRU Report 62. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). Series Editor. Bethesda, MD. 1999.
20. Jones B, Aird E, Colyer H, Dobbs J, Harris R, Hoskin P, et al. United kindom Radiation Oncology 1 Conference (UKRO1): Accuracy and uncertainty in radiotherapy. Br J Radiol 2002;75:297-306.
21. Khoo VS, Padhani AR, Tanner SF, Finnigan DJ, Leach MO, Dearnaley DP. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: A feasibility study. Br J Radiol 1999;72:590-7.
22. Lebesque JV, Bruce AM, Kroes AP, Touw A, Shouman RT, van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:1109-19.
23. Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Mohan R, Mageras GS, et al. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin Oncol 1994;21:580-97.
24. Logue JP, Sharrock CL, Cowan RA, Read G, Marrs J, Mott D. Clinical variability of target volume dscription in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 1998;41:929-31.
25. Madelis G, Carrie C, Ginestet C, Aletti P, Beckendorf V, Bey P, et al. Target volume and organs at risk definition variability: Apropos of a prostate cancer case. Physica Med 1998;14:90.
26. Mah D, Freedman G, Movsas B, Hanlon A, Mitra R, Horwitz E, et al. To move or not to move: Measurements of prostate motion by urethrography using MRI. Int J Radiat Oncol Biol Phys 2001;50:947-51.
27. Mah D, Steckner M, Hanlon A, Freedman G, Milestone B, Mitra R, et al. MRI simulation: Effect of gradient distortions on three-dimensional prostate cancer plans. Int J Radiat Oncol Biol Phys 2002;53:757-65.
28. Malone S, Crook JM, Kendal WS, Szanto J. Respiratory-induced prostate motion: Quantification and characterization. Int J Radiat Oncol Biol Phys 2000;48:105-9.
29. Malone S, Donker D, Broader M, Dahrouge S, Szanto J, Gerig L, et al. Effects of urethrography on prostate position: Considerations for radiotherapy treatment planning of prostate carcinoma. Int J Radiat Oncol Biol Phys 2000;46:89-93.
30. Malone S, Szanto J, Perry G, Gerig L, Manion S, Dahrouge S, et al. A prospective comparison of three systems of patient immobilization for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2000;48:657-65.
31. McNeal JE. Cancer volume and site of origine of adenocarcinoma in the prostate. Hum Pathol 1992;23:258-66.
32. Murphy D, Porter AT. Prostate localization for the treatment planning of prostate cancer: A comparison of two techniques. Med Dosim 1988;13:11-2.
33. Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Padhani AR, Webb S, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:649-56.
34. Nutting CM, Khoo VS, Walker V, McNair H, Beardmore C, Norman A, et al. A randomized study of the use of a customized immobilization system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol 2000;54:1-9.
35. Partin AW, Kattan MW, Subong EN, Walsch PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer, a multi-institutional update. JAMA 1997;277:1445-51.
36. Perez CA, Lee HK, Georgiou A, Logsdon MD, Lai PP, Lockett MA. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1993;26:581-91.
37. Pickett B, Fisch BM, Weinberg V. Dose to the bulb of the penis is associated with the risk of impotence following radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1999;45.
38. Pollack A, Zagars GK, Starkschall G, Childress CH, Kopplin S, Boyer AL, et al. Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys 1996;34:555-64.
39. Pollack A, Zagars G, Starkhall G, Antolak J, Lee JJ, kuban D, et al. Prostate cancer radiation dose response: Final planned analysis of a phase III randomized trial (abstract). Proc Am Soc Clin Oncol 2002;21:703.
40. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV. Definition of the prostate in CT and MRI: A multi-observer study. Int J Radiat Oncol Biol Phys 1999;43:57-66.
41. Remeijer P, Rasch C, Lebesque JV, van Herk M. A general methodology for three-dimensional analysis of variation in target volume delineation. Med Phys 1999;26:931-40.
42. Rosen MA, Goldstone L, Lapin S, Wheeler T, Scardino PT. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol 1992;148:331-7.
43. Rosenthal SA, Roach 3rd M, Goldsmith BJ, Doggett EC, Pickett B, Yuo HS, et al. Immobilization improves the reproducibility of patient positioning during six-field conformal radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 1993;27:921-6.
44. Sadeghi A, Kuisk H, Tran L, St Royal L. Urethrography and ischial intertuberosity line in radiation therapy planning for prostate carcinoma. Radiother Oncol 1996;38:215-22.
45. Seddon B, Bidmead M, Wilson J, Khoo V, Dearnaley D. Target volume definition in conformal radiotherapy for prostate cancer: Quality assurance in the MRC RT-01 trial. Radiother Oncol 2000;56:73-83.
46. Shipley WV. The advantage of an x-ray visible marker of the prostate apex. Editorial. Int J Radiat Oncol Biol Phys 1993;27:985.
47. Skwarchuk MW, Jackson A, Zelefsky MJ, Venkatraman ES, Cowen DM, Levegrun S, et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 2000;47:103-13.
48. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000;48:635-42.
49. Wachter S, Gerstner N, Dorner D, Goldner G, Colotto A, Wambersie A, et al. The influence of a rectalballoon tube as internal immobilization device on variation of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:91-100.
50. Weber DC, Nouet P, Rouzaud M, Miralbell R. Patient positioning in prostate radiotherapy: Is prone better than supine? Int J Radiat Oncol Biol Phys 2000;47:365-71.
51. Zelefsky MJ, Happersett L, Leibel SA, Burman CM, Schwartz L, Dicker AP, et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1997;37:13-9.
52. Zhou SM, Bentel GC, Lee CG, Anscher MS. Differences in gross target volumes on contrast vs. noncontrast CT scans utilized for conformal radiation therapy treatment planning for prostate carcinoma. Int J Radiat Oncol Biol Phys 1998;42:73-8.